VP, Corporate Controller
Michael J. Todisco joined Pear Therapeutics in February 2018 as Vice President, Corporate Controller. Prior to joining Pear, Mr. Todisco was Vice President, Finance at Karyopharm Therapeutics from September 2016 – January 2018. Mr. Todisco has been employed in VP Finance/Controller roles in the life sciences industry since 2005 by Dicerna Pharmaceuticals (2014-2016), BG Medicine (2013-2014) and DUSA Pharmaceuticals (2005-2013). Prior to 2005, Mr. Todisco spent several years in the software/high tech industry as a Director in finance positions at Art Technology Group, American Tower Corporation and Sapient Corporation. Mr. Todisco started his career in public accounting with both E&Y and KPMG. Mr. Todisco earned his MS in Accountancy from Northeastern University and his BA in Economics from Colgate University.